Death, Disability, and Premature Life Years Lost Due to Cigarettes, Bidis, and Smokeless Tobacco in India: A Comparative Assessment

Author:

Jain Yogesh Kumar1ORCID,Bhardwaj Pankaj2ORCID,Joshi Nitin Kumar3ORCID,Gupta Manoj Kumar2ORCID,Goel Akhil Dhanesh4ORCID,Sharma Prem Prakash4

Affiliation:

1. PhD Scholar, Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Jodhpur, India

2. Department of Community Medicine and Family Medicine, School of Public Health, All India Institute of Medical Sciences, Jodhpur, India

3. School of Public Health, All India Institute of Medical Sciences, Jodhpur, India

4. Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Jodhpur, India

Abstract

Background: Due to the staggering number of tobacco users in India, it is important to determine the exact mortality and morbidity rates due to tobacco use. This study aimed to estimate deaths, disability-adjusted life years (DALYs), and years of life lost (YLLs) attributable to cigarettes, bidis, and smokeless tobacco (SLT) in India. Methods: Data pooling and meta-analysis were done using case-control studies available on the three types of tobacco products. Health burden was estimated by applying the population attributable fraction (PAF) value to the total disease burden. Findings: A total of 33 studies were included. PAF was calculated for oral and lung cancer as well as ischemic heart disease (IHD) due to cigarettes, oral and lung cancer, IHD, and chronic obstructive pulmonary disease due to bidi, and oral and stomach cancer and IHD due to SLT. Cigarettes resulted in 8.4 million DALYs, 8.26 million YLLs, and 341 deaths; bidis led to 11.7 million DALYs, 10.7 million YLLs, and 478 thousand deaths, and SLTs accounted for 4.38 million DALYs, 4.3 million YLLs, and 171 thousand deaths annually. Conclusion: Evidence of measurable health burden and methodology for calculation for individual states was provided in the study. The generated evidence could be utilized for policy recommendations and revision of the existing taxation norms.

Publisher

Maad Rayan Publishing Company

Reference55 articles.

1. World Health Organization (WHO). Tobacco. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/tobacco#:~:text = The%20tobacco%20epidemic%20is%20one,level%20of%20exposure%20to%20tobacco. Accessed November 9, 2022.

2. Centers for Disease Control and Prevention. Tobacco-Related Mortality. 2020. Available from: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/tobacco_related_mortality/index.htm. Accessed November 9, 2022.

3. Global burden of disease due to smokeless tobacco consumption in adults: an updated analysis of data from 127 countries

4. Jha P, MacLennan M, Chaloupka FJ, Yurekli A, Ramasundarahettige C, Palipudi K, et al. Global hazards of tobacco and the benefits of smoking cessation and tobacco taxes. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, eds. Cancer: Disease Control Priorities. 3rd ed. Vol 3. Washington, DC: The International Bank for Reconstruction and Development, The World Bank; 2015. doi: 10.1596/978-1-4648-0349-9_ch10.

5. World Health Organization (WHO). Tobacco. Available from: https://www.who.int/india/health-topics/tobacco#:~:text = India%20is%20also%20the%20second,Survey%20India,%202016-17. Accessed November 9, 2022.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3